Comparison of PRS According to Inhalation Agent During LDLT

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01886664

Enrollment

Registered

2013-06-26

Start date

2012-12-31

Completion date

2013-12-31

Last updated

2014-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Transplantation, Postreperfusion Syndrome

Brief summary

The investigators tried to evaluate the effect of desflurane on the incidence of postreperfusion syndrome during living donor liver transplantation surgery. The investigators used sevoflurane as a comparison.

Interventions

DRUGDesflurane

DRUGsevoflurane

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* elective LDLT

Exclusion criteria

* age \< 18, age \> 65 * patient refusal * re-transplantation

Design outcomes

Primary

Measure	Time frame	Description
frequency of PRS	immediately after reperfusion	reperfusion syndrome occurs, if it occurs, immediately after reperfusion. Therefore, the primary outcome, reperfusion syndrome, can only be assessed immediately after reperfusion.

Secondary

Measure	Time frame
ICU length of stay	after LT until the patient is transferred to the ward

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026